We are live on
!
Find out more
JSP
Jackson Square Partners Portfolio holdings
AUM
$247M
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$20B
AUM Growth
+$311M
(+1.6%)
Cap. Flow
-$345M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
39.36%
Holding
96
New
5
Increased
25
Reduced
57
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$282M |
| 2 |
Domino's
DPZ
|
+$220M |
| 3 |
Take-Two Interactive
TTWO
|
+$174M |
| 4 |
New York Times
NYT
|
+$174M |
| 5 |
Applied Materials
AMAT
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
Meta Platforms (Facebook)
META
|
+$527M |
| 3 |
Crown Castle
CCI
|
+$118M |
| 4 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$114M |
| 5 |
Gen Digital
GEN
|
+$90M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.15% |
| 2 | Communication Services | 15.98% |
| 3 | Technology | 15.41% |
| 4 | Healthcare | 14.1% |
| 5 | Consumer Discretionary | 9.97% |
Similar funds
OIA
SRC
TCB
MTWM
SSW
WS
FC
KSWA
Jackson Square Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Jackson Square Partners held 96 positions worth $20B, up 1.6% from $19.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jackson Square Partners's Q1 2018 filing shows 5 new, 25 increased, 57 reduced and 7 closed positions. Its largest new stake was New York Times: 7,564,384 shares worth $182M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Technology.
- Jackson Square Partners's largest Q1 2018 buy was New York Times: 7,564,384 shares worth $182M.
- Jackson Square Partners added most to UnitedHealth in Q1 2018, an estimated $282M increase.
- Jackson Square Partners's biggest Q1 2018 reduction was Crown Castle, cutting an estimated $118M.
- Jackson Square Partners fully exited Celgene Corp in Q1 2018, selling an estimated $592M.
- Jackson Square Partners's ten largest holdings make up 39% of its $20B portfolio in Q1 2018.
- Jackson Square Partners opened 5 new positions and closed 7 in Q1 2018.
- Jackson Square Partners's portfolio value rose 1.6% quarter-over-quarter to $20B.
Based on Jackson Square Partners's 13F filing for Q1 2018, filed 14 May 2018.